Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$19.45 - $37.37 $143,988 - $276,650
-7,403 Reduced 36.97%
12,624 $245,000
Q1 2024

Apr 29, 2024

SELL
$36.08 - $54.3 $51,991 - $78,246
-1,441 Reduced 6.71%
20,027 $751,000
Q4 2023

Feb 07, 2024

SELL
$34.32 - $57.55 $78,009 - $130,811
-2,273 Reduced 9.57%
21,468 $1.2 Million
Q3 2023

Nov 02, 2023

BUY
$40.86 - $62.98 $38,735 - $59,705
948 Added 4.16%
23,741 $979,000
Q2 2023

Aug 07, 2023

SELL
$50.96 - $58.72 $24,970 - $28,772
-490 Reduced 2.1%
22,793 $1.27 Million
Q1 2023

May 09, 2023

SELL
$35.33 - $55.79 $85,039 - $134,286
-2,407 Reduced 9.37%
23,283 $1.3 Million
Q4 2022

Feb 09, 2023

BUY
$24.4 - $41.3 $102,748 - $173,914
4,211 Added 19.61%
25,690 $936,000
Q3 2022

Nov 09, 2022

SELL
$28.48 - $52.59 $35,571 - $65,684
-1,249 Reduced 5.5%
21,479 $612,000
Q2 2022

Aug 10, 2022

BUY
$36.95 - $82.41 $77,705 - $173,308
2,103 Added 10.2%
22,728 $1.03 Million
Q1 2022

May 09, 2022

SELL
$55.7 - $145.79 $68,232 - $178,592
-1,225 Reduced 5.61%
20,625 $1.57 Million
Q4 2021

Feb 09, 2022

SELL
$135.05 - $182.59 $807,734 - $1.09 Million
-5,981 Reduced 21.49%
21,850 $3.26 Million
Q3 2021

Nov 09, 2021

SELL
$145.58 - $192.14 $458,285 - $604,856
-3,148 Reduced 10.16%
27,831 $4.05 Million
Q2 2021

Aug 10, 2021

BUY
$134.22 - $202.37 $1.04 Million - $1.56 Million
7,731 Added 33.25%
30,979 $6.07 Million
Q1 2021

May 10, 2021

BUY
$140.25 - $196.86 $185,130 - $259,855
1,320 Added 6.02%
23,248 $4.21 Million
Q4 2020

Feb 08, 2021

BUY
$126.47 - $163.7 $1.29 Million - $1.67 Million
10,231 Added 87.47%
21,928 $3.11 Million
Q3 2020

Nov 06, 2020

SELL
$87.44 - $125.0 $92,511 - $132,250
-1,058 Reduced 8.29%
11,697 $1.46 Million
Q2 2020

Aug 05, 2020

BUY
$58.39 - $89.31 $744,764 - $1.14 Million
12,755 New
12,755 $1.14 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.